Evidence map›Paper›PMID 31603899›Full record

ArticlePloS one2019

Removal of anthracycline cytostatics from aquatic environment: Comparison of nanocrystalline titanium dioxide and decontamination agents.

Martin Šťastný, Václav Štengl, Irena Štenglová-Netíková, Michaela Šrámová-Slušná, Pavel Janoš

Open access · goldAbstract readComparative Study
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Martin ŠťastnýInstitute of Inorganic Chemistry of the Czech Academy of Sciences, Řež, Czech Republic.ORCID 0000-0003-1017-6491
Václav ŠtenglInstitute of Inorganic Chemistry of the Czech Academy of Sciences, Řež, Czech Republic.
Irena Štenglová-Netíková1st Faculty of Medicine, Charles University in Prague, Ovocný trh, Czech Republic.
Michaela Šrámová-SlušnáInstitute of Inorganic Chemistry of the Czech Academy of Sciences, Řež, Czech Republic.
Pavel JanošFaculty of the Environment, J.E.Purkyně University in Ústí nad Labem, Ústí nad Labem, Czech Republic.
Czech Academy of Sciences, Institute of Inorganic Chemistry · CZCharles University · CZJan Evangelista Purkyně University in Ústí nad Labem · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anthracyclines are a class of pharmaceuticals used in cancer treatment have the potential to negatively impact the environment. To study the possibilities of anthracyclines (represented by pirarubicin and valrubicin) removal, chemical inactivation using NaOH (0.01 M) and NaClO (5%) as decontamination agents and adsorption to powdered nanocrystalline titanium dioxide (TiO2) were compared. The titanium dioxide (TiO2) nanoparticles were prepared via homogeneous precipitation of an aqueous solution of titanium (IV) oxy-sulfate (TiOSO4) at different amount (5-120 g) with urea. The as-prepared TiO2 samples were characterized by XRD, HRSEM and nitrogen physisorption. The adsorption process of anthracycline cytostatics was determined followed by high-performance liquid chromatography coupled with mass spectrometry (LC-MS) and an in-situ Diffuse Reflectance Infrared Fourier Transform Spectroscopy (DRIFTS) technique. It was found that NaClO decomposes anthracyclines to form various transformation products (TPs). No TPs were identified after the reaction of valrubicin with a NaOH solution as well as in the presence of TiO2 nanoparticles. The best degree of removal, 100% of pirarubicin and 85% of valrubicin, has been achieved in a sample with 120 grams of TiOSO4 (TIT120) and TiO2 with 60 grams (TIT60), respectively.

Indexed as

AdsorptionCrystallizationCytostatic AgentsDecontaminationDoxorubicinHydrolysisNanostructuresParticle SizeSodium HydroxideSodium HypochloriteSurface PropertiesTitaniumWater Pollutants, ChemicalCytostatic AgentsDoxorubicinpirarubicinSodium HydroxideSodium HypochloriteTitaniumtitanium dioxidevalrubicinWater Pollutants, Chemical

Identifiers

PMID31603899
PMCPMC6788709
OpenAlexW2980086097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.